RE: finance11 May 2021 10:13
Hemo have borrowed £60m from Mint. They have so far drawn down £12m. Mint are converting at quite a pace to get back this £12m with profit. So far they have converted approx £4m so they have another £8m to go. There is no fixed conversion price or number of shares. So the lower the SP, the more shares Mint convert and therefore the more dilution. However, Mint cannot convert below 1p. See the prospectus or RNS for more information. Hemo at the moment have no other funding options that we are aware of. Additionally, they will have to pay back 114-120% if they cancel the CLN. If you are going to invest here, you really need to do some reading.